Načítá se...
Recurrent glioblastoma versus late posttreatment changes: diagnostic accuracy of O-(2-[(18)F]fluoroethyl)-L-tyrosine positron emission tomography ((18)F-FET PET)
BACKGROUND: Diagnostic accuracy in previous studies of O-(2-[(18)F]-fluoroethyl)-L-tyrosine ((18)F-FET) PET in patients with suspected recurrent glioma may be influenced by prolonged dynamic PET acquisitions, heterogeneous populations, different non–standard-of-care therapies, and PET scans performe...
Uloženo v:
| Vydáno v: | Neuro Oncol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6917428/ https://ncbi.nlm.nih.gov/pubmed/31618420 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz166 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|